Safety, Tolerability, and Pharmacokinetics of Lasmiditan When Co-administered With Topiramate in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 29 Nov 2019
Price : $35 *
At a glance
- Drugs Lasmiditan (Primary) ; Topiramate (Primary)
- Indications Migraine
- Focus Adverse reactions
- Sponsors Eli Lilly and Company
- 26 Jan 2018 Status changed from recruiting to completed.
- 20 Oct 2017 Status changed from not yet recruiting to recruiting.
- 17 Oct 2017 New trial record